CONNECTING Healthcare EXPERTISE

THE CLINICIAN EXCHANGE is a virtual exchange designed to pair specific clinical skillsets with specific industry initiatives.

EXCHANGE YOUR EXPERTISE

Learn how you can unlock the power of your expertise and experience to impact the healthcare industry in ways never before imagined

REGISTER NOWLEARN MORE

EXTEND, EXCEL…EXPLORE THE EXCHANGE

Learn how you can cost-effectively multiply your sales, education and R&D resources in an instant

REGISTER NOWLEARN MORE

COMMUNITY PORTAL

IN THE NEWS

CLINICIAN NEWS

Provided by: Medscape

Noninvasive Method May Tell Alzheimer's From FTD

Published: Tue, 15 Aug 2017 13:37:42 EDT
A new method using transcranial magnetic stimulation may help differentiate Alzheimer's disease from frontotemporal dementia, new research shows.
Medscape Medical News

NAMS' Hormone Therapy Statement: Primary Care Takeaways

Published: Tue, 15 Aug 2017 12:43:14 EDT
Who can safely take hormone therapy and for how long? Are there alternatives? Dr JoAnn Manson answers questions based on the new position statement from the North American Menopause Society.
Medscape Internal Medicine
Displaying results 19-20 (of 20)
 1 - 2 - 3 - 4 - 5 - 6 - 7 

HEALTHCARE SUPPLIER NEWS

Testing the safety of immunotherapy in diabetes

Published: Wed, 09 Aug 2017 18:05:59 +0000
Researchers have long been interested in using immunotherapy techniques to tamp down diabetes, but they’ve worried that they’ll accidentally make the disease worse. Now, researchers in the U.K. are describing a treatment that has proven safe and effective in a small trial.

CRUK, Biotecnol team up for T-cell engager trial

Published: Wed, 09 Aug 2017 15:55:51 +0000
Biotecnol has teamed up with Cancer Research UK (CRUK) to take its T-cell engager into the clinic. The agreement sees CRUK take a stake in the Anglo-Portuguese biotech in return for help testing a 5T4-CD3 bispecific antibody in patients with lung cancer and other solid tumors.

Melinta merges with faltering Cempra, bagging a Nasdaq listing and a pipeline of anti-infective programs

Published: Wed, 09 Aug 2017 13:23:08 +0000
Melinta Therapeutics has struck a deal to merge with Cempra. The agreement brings together two of the biotechs plugging away, with mixed success, at late-phase development of anti-infective drugs.
Displaying results 22-24 (of 25)
 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 

HAVE A QUESTION?

 Security code

Clinician Owned and Veteran Owned

copyright 2017 THE CLINICIAN EXCHANGE. Privacy Policy
Top